Literature DB >> 25647733

Side population cells and drug resistance in breast cancer.

Meijian Wang1, Yaqi Wang1, Jun Zhong1.   

Abstract

Several studies have demonstrated that the isolated side population (SP) cells from solid tumors exhibit cancer stem cell‑like properties, and are responsible for drug resistance during chemotherapy and tumor recurrence. In the current study, cancer stem cell‑like SP cells were isolated in the MDU‑22 breast cancer cell line using the Hoechst‑33342 dye exclusion technique. It was observed that SP cells accounted for 3.8% of cells in the MDU‑22 cell line, which was reduced to 0.6% in the presence of verapamil, an inhibitor of the ABC transporter. The sorted SP cells showed an elevated expression of stem cell markers, including ABCG2, OCT‑4 and EpCAM. Furthermore, it was demonstrated that the isolated SP cells undergo rapid proliferation and have a high survival rate. These results indicate that the coexpression of adenosine triphosphatase binding cassette transporters and stem cell surface markers in SP cells may contribute to chemoresistance, tumor recurrence, metastasis and invasion. Therefore, the isolation and characterization of SP cells may provide novel insights for the development of alternative therapeutic agents to target cancer stem cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25647733     DOI: 10.3892/mmr.2015.3291

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  16 in total

Review 1.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

2.  Combined effects of octreotide and cisplatin on the proliferation of side population cells from anaplastic thyroid cancer cell lines.

Authors:  Zhilan Li; Xiudi Jiang; Peihong Chen; Xuebing Wu; Aihua Duan; Yiyu Qin
Journal:  Oncol Lett       Date:  2018-07-10       Impact factor: 2.967

3.  Abnormal activation of notch 1 signaling causes apoptosis resistance in cervical cancer.

Authors:  Lu Yu; Wei Li
Journal:  Int J Clin Exp Pathol       Date:  2022-01-15

4.  Isocyclopamine, a novel synthetic derivative of cyclopamine, reverts doxorubicin resistance in MCF-7/ADR cells by increasing intracellular doxorubicin accumulation and downregulating breast cancer stem-like cells.

Authors:  Ming Liu; Weiyi Zhang; Wei Tang; Yanjuan Wang; Xingzeng Zhao; Xiangyun Wang; Xin Qi; Jing Li
Journal:  Tumour Biol       Date:  2015-09-02

Review 5.  Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?

Authors:  Axel Schulenburg; Katharina Blatt; Sabine Cerny-Reiterer; Irina Sadovnik; Harald Herrmann; Brigitte Marian; Thomas W Grunt; Christoph C Zielinski; Peter Valent
Journal:  J Hematol Oncol       Date:  2015-02-25       Impact factor: 17.388

6.  Expression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes.

Authors:  Jun Hu; Jian Li; Xin Yue; Jiacang Wang; Jianzhong Liu; Lin Sun; Dalu Kong
Journal:  Oncotarget       Date:  2017-04-25

7.  Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells.

Authors:  Ming Liu; Hua Yin; Xiaokun Qian; Jianjun Dong; Zhonghua Qian; Jinlai Miao
Journal:  Molecules       Date:  2016-12-28       Impact factor: 4.411

8.  Breast Cancer Heterogeneity: A focus on Epigenetics and In Vitro 3D Model Systems.

Authors:  Palamadai Krishnan Suresh
Journal:  Cell J       Date:  2018-05-15       Impact factor: 2.479

9.  Possibility of cancer-stem-cell-targeted radioimmunotherapy for acute myelogenous leukemia using 211At-CXCR4 monoclonal antibody.

Authors:  Noboru Oriuchi; Miho Aoki; Naoyuki Ukon; Kohshin Washiyama; Chengbo Tan; Saki Shimoyama; Ken-Ichi Nishijima; Kazuhiro Takahashi; Hiroshi Ito; Takayuki Ikezoe; Songji Zhao
Journal:  Sci Rep       Date:  2020-04-22       Impact factor: 4.379

10.  Hepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapy.

Authors:  Yongqiang Zhan; Lisha Mou; Kangwen Cheng; Chengyou Wang; Xuesong Deng; Junren Chen; Zhibing Fan; Yong Ni
Journal:  Oncol Lett       Date:  2016-08-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.